Mental Health Clinics in New Eagle, PA Accepting Medicare
1 Mental Health Clinics found. Showing 1 - 1
 Real Talk Counseling Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 134 Main St, New Eagle, PA 15067 Phone: 412-302-7170 |
News Archive
Lancet analysis examines trends in preterm birth, potential interventions in developed countries
An analysis published Thursday in the Lancet examines trends in and interventions for preterm birth in 39 developed countries, with the authors writing, "Shockingly, very little reduction is currently possible," Examiner.com reports.
Dermatologist discusses treatment for acne and melasma
The U.S. Census Bureau predicts that the Asian-American population will total 40 million people by 2050. While as a whole this group is characterized by very dark hair and dark eyes, there is much diversity in Asian skin tones – from very light, pale skin to light or dark brown skin. One common thread is the pigmentation issues that Asian Americans often face as after-effects of other dermatologic problems that can be as troublesome as the original condition itself.
Metastatic melanoma: Involvement of immune system in response to PV-10 therapy
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that Dr. Sanjiv Agarwala, in his presentation at the Seventh International Symposium on Melanoma and Other Cutaneous Malignancies on March 12, 2010, commented on the involvement of the immune system in response to PV-10 therapy and its role in the "bystander effect" in treating metastatic melanoma. Dr. Agarwala's presentation, entitled "Chemoablation in Melanoma: An Update," was given in the session entitled "Unique Approaches to Melanoma Therapy."
Dicerna Pharmaceuticals, Ipsen announce collaboration in DsiRNA research and peptide engineering
Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company, and Ipsen, a global biotechnology specialty care group, announced today that the two companies have entered into an exclusive research collaboration agreement to leverage their expertise in Dicer Substrate siRNA (DsiRNA) research and peptide engineering. The companies will develop novel conjugates of Dicerna's DsiRNA molecules and Ipsen's peptide targeting vectors in the therapeutic areas of oncology and endocrinology.
Chronix' DNA blood tests detect prostate, breast cancer with 92% sensitivity and 100% specificity
Chronix Biomedical today reported new data further demonstrating that its DNA blood tests have the potential to accurately detect early stage breast and prostate cancers. Chronix's proprietary technology identifies disease-specific genetic fingerprints based on DNA fragments that are released into the bloodstream by damaged and dying (apoptotic) cells.
› Verified 4 days ago